News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Why More Clinical Laboratory Sales Managers Are Failing in Today’s Fast-Evolving Healthcare Marketplace

Sales managers at top-performing medical labs and pathology groups are directing the lab sales reps to develop new clients who can refer lab tests that are still adequately reimbursed

In today’s rough-and-tumble healthcare marketplace, every clinical laboratory and pathology group needs a sales manager or sales vice president who is at that top of the game in managing productive sales reps, achieving growth targets, and strengthening their lab’s financial stability.

Labs with strong sales leaders are doing much better financially at a time when payers are slashing the prices they pay for medical laboratory tests. (more…)

Clinical Lab Industry Should Prepare for Many Marketplace Changes, Predict Experts at Yesterday’s Executive War College

Labs are facing new threats as managed care plans cut reimbursement levels and new companies are coming between labs and their physician clients

*** Revised Version – Original Version Misstated: The previous version had statements attributed to Ignis Systems that were incorrect. The corrected version is below.

DATELINE: NEW ORLEANS, LOUISIANA—It was a big opening for the 17th annual Executive War College (EWC) on Laboratory and Pathology Management yesterday. A record crowd of about 700 enthusiastic clinical laboratory managers and pathologists heard lab industry leaders predict a fast-changing future for the medical laboratory testing industry.

The editorial team from The Dark Report and Dark Daily are all here to cover the sessions and provide you with useful intelligence and insights about market trends and innovations in the management and operations of clinical laboratories. That was true of yesterday’s opening general session, followed by an afternoon of clinical laboratory management case studies.
(more…)

Clinical Labs Make Money by Using Revenue Cycle Management

Management Tool Contributes to More Collected Revenue, Higher Sales Prices

Revenue Cycle Management (RCM) is hitting the radar screen at the nation’s best-managed clinical laboratories. That’s because shrinking reimbursement makes it imperative for clinical labs and pathology groups to collect every dollar legally due for the lab testing services they provide. RCM is a proven management tool for reducing unpaid claims and unlocking more productivity in the coding/billing/collections process.

“Revenue Cycle Management for laboratories encompasses all the administrative and management functions that contribute to the capture, and collection of revenue associated with lab testing services,” observed Lale White, CEO of Xifin, Inc. of San Diego, California. White has been an acknowledged national expert in laboratory coding, billing, and collections for more than two decades.

(more…)

Daschle Tells Lab Executives to Expect Cost Cuts as Part of Health Reform

Ex-Senate Majority Leader Predicts Democrats Will Aggressively Push Reform

In recent weeks, laboratory professionals got a ringside seat to hear a true Washington insider discuss key issues in healthcare reform. Former U.S. Senate Majority Leader Tom Daschle, told lab industry executives and pathologists that Congress faces three significant hurdles as it attempts to reform the healthcare system. The first—and perhaps most significant—hurdle involves costs, he said. Daschle is currently a Senior Policy Advisor at Alston and Bird, a law firm in Washington, D.C.

“Cost is a huge political factor,” stated Daschle during a recent audio conference conducted by the American Clinical Laboratory Association (ACLA) on June 24. “Of all of the factors, cost is driving this debate as much if not more than any [other single factor]. We are looking at an investment cost of about $1 trillion to put this new infrastructure in place and that is an issue of great concern.” Daschle explained that the other two hurdles are quality of care and access to healthcare.
(more…)

;